Work

Efficacy of supraglottic airway devices in chest compression synchronized ventilation during continuous resuscitation: a prospective randomized cross-over cadaver study

Year: 2025

Type: article

Abstract: BACKGROUND: This study aimed to evaluate the efficacy of Chest-Compression-Synchronized-Ventilation (CCSV) using supraglottic airway devices (SGA) compared to tracheal intubation (TI) for ventilation during continuous resuscitation. METHODS: ). Logistic regression models with random intercepts were used for the primary outcome, and linear mixed models were applied for secondary outcomes. RESULTS: (RC = -55.03 %; 95 %CI = [-62.92-47.15]; p < 0.0001). In comparisons among the individual SGA, lower pCCSV-values were observed for Ambu®AuraGain™ versus I-GEL® (RC = -2.58 mbar; 95 %CI = [-4.04--1.13]; p = 0.0006), Ambu®AuraGain™ versus LTS-D® (RC = -1.73 mbar; 95 %CI = [-3.18--0.27]; p = 0.0204), and LTS-D® versus I-GEL® (RC = -0.86 mbar; 95 %CI = [-2.30-0.59]; p = 0.2434). CONCLUSION: . Regardless the airway device, CCSV-failure is possible emphasizing the need for vigilant respiratory monitoring. REGISTRATION: URL: https://www. CLINICALTRIALS: gov. Unique identifier number: NCT06306898.

Source: Resuscitation

DOI: 10.1016/j.resuscitation.2025.110795